Product Program year 2025 Source: CMS Open Payments

Dreamtome RX 49

Device Dreamtome_ENDO

PDI 08714729778226

Open in the dashboard

General payments

$5,035

203 payments

Research payments

$0

0 payments

Through program year 2025, $5,035 in general payments and $0 in research payments were reported against Dreamtome RX 49 (Dreamtome_ENDO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,192 40
2024 General $1,519 92
2023 General $1,496 45
2022 General $827 26

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $5,035 203 payments
Top recipients General payments · program year 2025
  1. Ikponmwosa Enofe Gastroenterology · Stanford, CA $129 11% · 1 payment
  2. Smit Deliwala Atlanta, GA $129 11% · 1 payment
  3. Adib Chaaya Gastroenterology · Mount Laurel, NJ $107 9% · 1 payment
  4. Samuel Giordano Internal Medicine · Mount Laurel, NJ $107 9% · 1 payment
  5. Adam Elfant Gastroenterology · Mount Laurel, NJ $107 9% · 1 payment

The top 5 of 28 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $596 56% · 13 practitioners
  2. Internal Medicine $219 21% · 6 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $136 13% · 3 practitioners
  4. Surgery $40 4% · 1 practitioner
  5. Cardiovascular Disease Internal Medicine $23 2% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $336 28% · 4 recipients
  2. New York $240 20% · 5 recipients
  3. California $163 14% · 3 recipients
  4. Georgia $161 14% · 2 recipients
  5. Alabama $83 7% · 3 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

203 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record